Ignite Creation Date:
2024-05-06 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03668353
Status:
UNKNOWN
Last Update Posted:
2018-10-25
First Post:
2018-09-08
Brief Title:
Recombinant SeV-hFGF2dF Injection for PAOD
Sponsor:
Shenzhen Salubris Pharmaceuticals Co Ltd
Organization:
Shenzhen Salubris Pharmaceuticals Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Critical Limb Ischemia |
| PAOD - Peripheral Arterial Occlusive Disease |
| PAD |
Keywords: